{"id":"https://openalex.org/W4408200213","doi":"https://doi.org/10.1016/j.tranon.2025.102337","title":"Targeting FEN1/EXO1 to enhance efficacy of PARP inhibition in triple-negative breast cancer","display_name":"Targeting FEN1/EXO1 to enhance efficacy of PARP inhibition in triple-negative breast cancer","publication_year":2025,"publication_date":"2025-03-06","ids":{"openalex":"https://openalex.org/W4408200213","doi":"https://doi.org/10.1016/j.tranon.2025.102337","pmid":"https://pubmed.ncbi.nlm.nih.gov/40054125"},"language":"en","primary_location":{"id":"doi:10.1016/j.tranon.2025.102337","doi":"https://doi.org/10.1016/j.tranon.2025.102337","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2025.102337","pdf_url":null,"source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.tranon.2025.102337","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067323608","display_name":"Mallory I. Frederick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142730","display_name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0410a8y51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405273474","display_name":"Institut du cancer de Montr\u00e9al","ror":"https://ror.org/05w6ffd16","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4405273474"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mallory I. Frederick","raw_affiliation_strings":["Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3C 3T5, Canada; Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3C 3T5, Canada; Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada","institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I4405273474","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071864807","display_name":"Elicia Fyle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142730","display_name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0410a8y51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405273474","display_name":"Institut du cancer de Montr\u00e9al","ror":"https://ror.org/05w6ffd16","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4405273474"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Elicia Fyle","raw_affiliation_strings":["Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3C 3T5, Canada; Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3C 3T5, Canada; Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada","institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I4405273474","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050797213","display_name":"Anna Clouvel","orcid":"https://orcid.org/0009-0008-7380-5666","observed_orcids":["https://orcid.org/0009-0008-7380-5666"]},"institutions":[{"id":"https://openalex.org/I4210142730","display_name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0410a8y51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405273474","display_name":"Institut du cancer de Montr\u00e9al","ror":"https://ror.org/05w6ffd16","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4405273474"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Anna Clouvel","raw_affiliation_strings":["Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada"],"raw_orcid":"https://orcid.org/0009-0008-7380-5666","affiliations":[{"raw_affiliation_string":"Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada","institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I4405273474"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094222092","display_name":"Djihane Abdesselam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142730","display_name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0410a8y51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405273474","display_name":"Institut du cancer de Montr\u00e9al","ror":"https://ror.org/05w6ffd16","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4405273474"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Djihane Abdesselam","raw_affiliation_strings":["Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3C 3T5, Canada; Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3C 3T5, Canada; Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada","institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I4405273474","https://openalex.org/I70931966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066358109","display_name":"Saima Noor Hassan","orcid":"https://orcid.org/0000-0003-0232-2807","observed_orcids":["https://orcid.org/0000-0003-0232-2807"]},"institutions":[{"id":"https://openalex.org/I4210142730","display_name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0410a8y51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405273474","display_name":"Institut du cancer de Montr\u00e9al","ror":"https://ror.org/05w6ffd16","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4405273474"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Saima Hassan","raw_affiliation_strings":["Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3C 3T5, Canada; Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada; Division of Surgical Oncology, Department of Surgery, Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM), Montreal, QC H2X0C1, Canada. Electronic address: saima.hassan@umontreal.ca"],"raw_orcid":"https://orcid.org/0000-0003-0232-2807","affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3C 3T5, Canada; Centre de Recherche du Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM), l'Institut de Cancer de Montreal, Montreal, QC H2X0A9, Canada; Division of Surgical Oncology, Department of Surgery, Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM), Montreal, QC H2X0C1, Canada. Electronic address: saima.hassan@umontreal.ca","institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I4405273474","https://openalex.org/I70931966"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5066358109"],"corresponding_institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I4405273474","https://openalex.org/I70931966"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":1.7996,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.85442965,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"54","issue":null,"first_page":"102337","last_page":"102337"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8999999761581421},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/parp-inhibitor-resistance","display_name":"PARP inhibitor resistance","score":0.8209999799728394},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6650000214576721},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.9629999995231628},{"id":"https://openalex.org/keywords/g2-m-cell-cycle-arrest","display_name":"G2/M cell cycle arrest","score":0.7440000176429749},{"id":"https://openalex.org/keywords/olaparib-resistance","display_name":"olaparib resistance","score":0.8529999852180481},{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9380000233650208},{"id":"https://openalex.org/keywords/brca2-mutation","display_name":"BRCA2 mutation","score":0.46700000762939453},{"id":"https://openalex.org/keywords/synergistic-drug-combination","display_name":"synergistic drug combination","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7536921501159668},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6580214500427246},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5896582007408142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5381027460098267},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.5172591805458069},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.4675394892692566},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.399367094039917},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.379886656999588},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3227698802947998},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28428971767425537},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.1969650685787201},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.19502797722816467},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.11128506064414978}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.tranon.2025.102337","doi":"https://doi.org/10.1016/j.tranon.2025.102337","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2025.102337","pdf_url":null,"source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},{"id":"doi:10.1101/2024.10.01.616136","doi":"https://doi.org/10.1101/2024.10.01.616136","is_oa":false,"landing_page_url":"https://doi.org/10.1101/2024.10.01.616136","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmid:40054125","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40054125","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11928819","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11928819","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Transl Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.tranon.2025.102337","doi":"https://doi.org/10.1016/j.tranon.2025.102337","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.tranon.2025.102337","pdf_url":null,"source":{"id":"https://openalex.org/S106638657","display_name":"Translational Oncology","issn_l":"1936-5233","issn":["1936-5233","1944-7124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Translational Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.4000000059604645,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G638276703","display_name":"Soutien \u00e0 la recherche pour l'\u00e9tablissement de la rel\u00e8ve professorale \u2014 Cancer du sein, G\u00e9notype et ph\u00e9notype","funder_award_id":"265384","funder_id":"https://openalex.org/F4320334618","funder_display_name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9"}],"funders":[{"id":"https://openalex.org/F4320323175","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34"},{"id":"https://openalex.org/F4320331692","display_name":"Institut Du Cancer de Montr\u00e9al","ror":"https://ror.org/05w6ffd16"},{"id":"https://openalex.org/F4320334618","display_name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","ror":"https://ror.org/02eqrsj93"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1975775716","https://openalex.org/W1977859620","https://openalex.org/W1986724703","https://openalex.org/W2094646262","https://openalex.org/W2103562758","https://openalex.org/W2106085357","https://openalex.org/W2131271579","https://openalex.org/W2140480038","https://openalex.org/W2162451014","https://openalex.org/W2169456326","https://openalex.org/W2179438025","https://openalex.org/W2469726318","https://openalex.org/W2556440819","https://openalex.org/W2597062310","https://openalex.org/W2627871710","https://openalex.org/W2756935441","https://openalex.org/W2773981699","https://openalex.org/W2810748925","https://openalex.org/W2852866740","https://openalex.org/W2914604310","https://openalex.org/W2949415937","https://openalex.org/W2954021097","https://openalex.org/W2963279792","https://openalex.org/W2965681656","https://openalex.org/W2979841690","https://openalex.org/W3007516256","https://openalex.org/W3014487494","https://openalex.org/W3046182546","https://openalex.org/W3090010902","https://openalex.org/W3108403304","https://openalex.org/W3134817476","https://openalex.org/W3134914296","https://openalex.org/W3176275742","https://openalex.org/W4200437485","https://openalex.org/W4211006558","https://openalex.org/W4220864127","https://openalex.org/W4281751781","https://openalex.org/W4286611258","https://openalex.org/W4306146226","https://openalex.org/W4316804884","https://openalex.org/W4322500012","https://openalex.org/W4328049371","https://openalex.org/W4377116115","https://openalex.org/W4391147264","https://openalex.org/W4391679849","https://openalex.org/W4391839664","https://openalex.org/W4393319291","https://openalex.org/W4401973294","https://openalex.org/W6730340163"],"related_works":["https://openalex.org/W2548423821","https://openalex.org/W2808928250","https://openalex.org/W2604684522","https://openalex.org/W4236143807","https://openalex.org/W2888002479","https://openalex.org/W4404135914","https://openalex.org/W1990291556","https://openalex.org/W2583515325","https://openalex.org/W4391303254","https://openalex.org/W2061827661"],"abstract_inverted_index":{"Abstract":[0],"Patients":[1],"with":[2,24,29,57,73,101,110,181],"triple-negative":[3],"breast":[4],"cancer":[5],"(TNBC)":[6],"have":[7,15],"limited":[8],"targeted":[9,241],"therapeutic":[10,237],"options.":[11],"PARP":[12],"inhibitors":[13],"(PARPi)":[14],"demonstrated":[16,89],"an":[17],"important":[18],"role":[19,214],"for":[20],"BRCA":[21],"-mutant":[22,98],"patients":[23],"early":[25],"TNBC.":[26,250],"Combination":[27],"approaches":[28],"PARPi":[30,36,58,81,120,171],"can":[31],"broaden":[32],"the":[33,78,137,156,203,212,246],"use":[34],"of":[35,41,80,115,119,150,202,215,227,248],"to":[37,104,164,225],"a":[38,74,111,128,178,182,240],"larger":[39],"cohort":[40],"TNBC":[42,93],"patients.":[43],"We":[44],"selected":[45],"six":[46],"genes":[47],"from":[48],"our":[49],"previously":[50],"identified":[51],"63-gene":[52],"signature":[53],"that":[54,211],"was":[55,88,107],"associated":[56],"response.":[59],"siFEN1":[60],"increased":[61,173,191],"cells":[62],"in":[63,82,91,127,143,162,177,185,200,218,245],"G2/M":[64],"arrest,":[65],"DNA":[66,144,151,192],"damage":[67,193],"and":[68,86,121,148,170],"particularly":[69,244],"apoptosis.":[70],"Targeting":[71],"FEN1":[72,122,168,216,234],"chemical":[75],"inhibitor":[76],"enhanced":[77],"efficacy":[79,139],"7/10":[83],"cell":[84,94,99,179,205,220],"lines,":[85],"synergy":[87,126],"mainly":[90],"PARPi-resistant":[92,129,219,249],"lines.":[95,206],"A":[96],"BRCA2":[97],"line":[100,180],"acquired":[102],"resistance":[103],"olaparib":[105],"(HCC1395-OlaR)":[106],"strongly":[108],"synergistic,":[109],"combination":[112,118,154,189,242],"index":[113],"value":[114],"0.20.":[116],"The":[117,153,188],"inhibition":[123,169,217],"also":[124,190],"showed":[125],"xenograft-derived":[130],"organoid":[131],"model.":[132],"Two":[133],"mechanisms":[134],"which":[135],"explain":[136],"underlying":[138],"are":[140],"rapid":[141],"progression":[142],"replication":[145,186],"fork":[146,158,174],"speed":[147,159,175],"enhancement":[149],"damage.":[152],"induced":[155],"highest":[157],"(47%":[160],"difference":[161],"comparison":[163],"control,":[165],"P<0.0001)":[166],"when":[167],"equally":[172],"individually":[176],"pre-existing":[183],"increase":[184],"stress.":[187],"at":[194],"lower":[195],"drug":[196],"concentrations,":[197],"driving":[198],"response":[199],"most":[201],"synergistic":[204],"Gene":[207],"expression":[208],"analysis":[209],"suggested":[210],"sensitizing":[213],"lines":[221],"may":[222],"be":[223],"due":[224],"downregulation":[226],"pathways":[228],"including":[229],"mismatch":[230],"repair.":[231],"Therefore,":[232],"targeting":[233],"shows":[235],"great":[236],"potential":[238],"as":[239],"approach,":[243],"context":[247]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}